Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

December 5, 2019

Study Completion Date

December 5, 2019

Conditions
Contour
Interventions
DRUG

BELKYRA®

BELKYRA® was injected into preplatysma fat tissue in the submental area (at least 1 plus up to 5 optional treatments, for maximum of 6 treatments 8 weeks apart).

DEVICE

Juvéderm® VOLUMA™ with Lidocaine

Juvéderm® VOLUMA™ with Lidocaine VOLUMA™ was injected along the mandibular border.

Trial Locations (3)

2010

Darlinghurst Dermatology, Darlinghurst

3002

Living Art, East Melbourne

3141

Dermatology Institute of Victoria, South Yarra

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY